Author

James Hugh Park

Institute for Systems BiologyORCID 0000-0002-6551-2037Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Organism:human· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adrián López García de LomanaiD· 2 shared Anoop P. PateliD· 2 shared Nitin S. BaligaiD· 2 shared Serdar TurkarslaniD· 2 shared Wei‐Ju WuiD· 2 shared Abdullah Hamid FerozeiD· 1 shared Anca B. Mihalas· 1 shared Charles CobbsiD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Adrián López García de LomanaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systems BiologyScience AdvancesPeer-reviewedJun 7, 2024

Gene Regulatory Network topology governs resistance and treatment escape in glioma stem-like cells

James Hugh Park, Parvinder Hothi, Adrián López García de Lomana…·Nitin S. Baliga

The paper shows how gene regulatory network topology in glioma stem-like cells influences drug resistance and treatment escape, suggesting strategies to overcome resistance through combinatorial therapies.

26 citationstop 2%

humanscRNA-seq

𝕏 PostBluesky

Systems Biologynpj Precision OncologyPeer-reviewedAug 8, 2022

A single-cell based precision medicine approach using glioblastoma patient-specific models

James Hugh Park, Abdullah Hamid Feroze, Samuel Emerson…·Anoop P. Patel

The paper uses single-cell analysis of GBM patient samples and xenografts to identify regulatory networks driving treatment-induced tumor evolution and proposes a framework for precision medicine.

35 citationstop 3%

mousehuman

𝕏 PostBluesky